phenyl acetate has been researched along with Brain Injury, Chronic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fang, SH; Shi, WZ; Wei, EQ; Zhang, YM; Zhao, R | 1 |
| WENZEL, E | 1 |
2 other study(ies) available for phenyl acetate and Brain Injury, Chronic
| Article | Year |
|---|---|
Montelukast, a cysteinyl leukotriene receptor-1 antagonist, attenuates chronic brain injury after focal cerebral ischaemia in mice and rats.
Topics: Acetates; Administration, Oral; Animals; Antipyrine; Atrophy; Behavior, Animal; Brain Injury, Chronic; Chromones; Cyclopropanes; Disease Models, Animal; Drug Evaluation, Preclinical; Edaravone; Free Radical Scavengers; Infarction, Middle Cerebral Artery; Injections, Intraperitoneal; Leukotriene Antagonists; Male; Mice; Mice, Inbred ICR; Nerve Degeneration; Quinolines; Rats; Rats, Sprague-Dawley; Sulfides | 2011 |
[Preliminary results of treatment of chronic brain injury with Helfergin].
Topics: Acetates; Brain; Brain Damage, Chronic; Brain Injuries; Brain Injury, Chronic; Central Nervous System Stimulants; Humans; Meclofenoxate | 1963 |